PDF
Full
Outline
Corporate venture capital (CVC) plays a huge role as a tool for parent companies to seek external innovation and obtain return on investment. The biopharmaceutical industry itself has high requirements for knowledge and innovation, and is in a stage of rapid development around the world. Therefore, CVC in the biopharmaceutical industry ecosystem is increasingly important. This paper analyzes the CVC development and trends of American pharmaceutical companies, and summarizes the investment data of well-known American pharmaceutical companies CVC in recent years. Fosun Health Capital, as a CVC of Fosun Pharma, is analyzed in this paper as a leading example of Chinese pharmaceutical company CVC. Finally, this paper summarizes the advantages and disadvantages of CVC in the biopharmaceutical industry and expects Chinese pharmaceutical companies to seize the opportunity during the rapid development of the industry and make CVC to become an important part of the Chinese biopharmaceutical industry ecosystem.
PDF
46
15
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62199257
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
